🦊/People

Dr. James Rothman

Investor

Senior Advisor at Celesta Capital

Find your path to Dr. James Rothman

34 people in our graph share verified history with Dr. James Rothman — schools, employers, funds. One of them is your warm intro.

Sarah LucasunlockedDr. James Rothman: together at Celesta Capital
×11Dr. James Rothman: together at Celesta Capital

About

Dr. James Rothman is a biomedical researcher who joined Celesta Capital as a Senior Advisor supporting the firm's bio-convergence strategy. He received the 2013 Nobel Prize in Physiology or Medicine for discoveries on the transfer of materials among cells, and serves as Chairman of the Yale School of Medicine's Department of Cell Biology and Director of Yale's Nanobiology Institute. His prior roles include Chief Scientist of General Electric Healthcare and faculty positions at Stanford, Princeton, Columbia, and Memorial Sloan-Kettering Cancer Center.

Invests in

BiotechDeep TechHealthtech

Colleagues at Celesta Capital

Frequently asked questions

Who is Dr. James Rothman?
Dr. James Rothman is a biomedical researcher who joined Celesta Capital as a Senior Advisor supporting the firm's bio-convergence strategy. He received the 2013 Nobel Prize in Physiology or Medicine for discoveries on the transfer of materials among cells, and serves as Chairman of the Yale School of Medicine's Department of Cell Biology and Director of Yale's Nanobiology Institute. His prior roles include Chief Scientist of General Electric Healthcare and faculty positions at Stanford, Princeton, Columbia, and Memorial Sloan-Kettering Cancer Center.
Where does Dr. James Rothman work?
Dr. James Rothman is Senior Advisor at Celesta Capital.
What does Dr. James Rothman invest in?
Dr. James Rothman invests in Biotech, Deep Tech, Healthtech.